These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31141025)
1. Mining in Twitter for adverse events from malaria drugs: the case of doxycycline. Duval FV; Silva FABD Cad Saude Publica; 2019 May; 35(5):e00033417. PubMed ID: 31141025 [TBL] [Abstract][Full Text] [Related]
2. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis. Zhou Z; Hultgren KE JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889 [TBL] [Abstract][Full Text] [Related]
3. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data. Ibrahim H; Saad A; Abdo A; Sharaf Eldin A J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152 [TBL] [Abstract][Full Text] [Related]
4. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports. Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292 [TBL] [Abstract][Full Text] [Related]
5. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016. Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003 [TBL] [Abstract][Full Text] [Related]
6. Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams. Eshleman R; Singh R BMC Bioinformatics; 2016 Oct; 17(Suppl 13):335. PubMed ID: 27766937 [TBL] [Abstract][Full Text] [Related]
7. Social Media Listening for Routine Post-Marketing Safety Surveillance. Powell GE; Seifert HA; Reblin T; Burstein PJ; Blowers J; Menius JA; Painter JL; Thomas M; Pierce CE; Rodriguez HW; Brownstein JS; Freifeld CC; Bell HG; Dasgupta N Drug Saf; 2016 May; 39(5):443-54. PubMed ID: 26798054 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Pierce CE; Bouri K; Pamer C; Proestel S; Rodriguez HW; Van Le H; Freifeld CC; Brownstein JS; Walderhaug M; Edwards IR; Dasgupta N Drug Saf; 2017 Apr; 40(4):317-331. PubMed ID: 28044249 [TBL] [Abstract][Full Text] [Related]
9. Filtering big data from social media--Building an early warning system for adverse drug reactions. Yang M; Kiang M; Shang W J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695 [TBL] [Abstract][Full Text] [Related]
10. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database. Roberto G; Piccinni C; D'Alessandro R; Poluzzi E Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799 [TBL] [Abstract][Full Text] [Related]
11. A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches. Pham M; Cheng F; Ramachandran K Drug Saf; 2019 Jun; 42(6):743-750. PubMed ID: 30762164 [TBL] [Abstract][Full Text] [Related]
12. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Freifeld CC; Brownstein JS; Menone CM; Bao W; Filice R; Kass-Hout T; Dasgupta N Drug Saf; 2014 May; 37(5):343-50. PubMed ID: 24777653 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology. Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093 [TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project. Gattepaille LM; Hedfors Vidlin S; Bergvall T; Pierce CE; Ellenius J Drug Saf; 2020 Aug; 43(8):797-808. PubMed ID: 32410156 [TBL] [Abstract][Full Text] [Related]
15. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review. Golder S; O'Connor K; Wang Y; Klein A; Gonzalez Hernandez G JMIR Public Health Surveill; 2024 Sep; 10():e59167. PubMed ID: 39240684 [TBL] [Abstract][Full Text] [Related]
16. Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR. Dietrich J; Gattepaille LM; Grum BA; Jiri L; Lerch M; Sartori D; Wisniewski A Drug Saf; 2020 May; 43(5):467-478. PubMed ID: 31997289 [TBL] [Abstract][Full Text] [Related]
17. Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions. Li Y; Jimeno Yepes A; Xiao C Drug Saf; 2020 Sep; 43(9):893-903. PubMed ID: 32385840 [TBL] [Abstract][Full Text] [Related]
18. Comparing drug safety of hepatitis C therapies using post-market data. Huang J; Zhang X; Tong J; Du J; Duan R; Yang L; Moore JH; Tao C; Chen Y BMC Med Inform Decis Mak; 2019 Aug; 19(Suppl 4):147. PubMed ID: 31391106 [TBL] [Abstract][Full Text] [Related]
19. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database. Welch HK; Kellum JA; Kane-Gill SL Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524 [TBL] [Abstract][Full Text] [Related]
20. Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. Comfort S; Perera S; Hudson Z; Dorrell D; Meireis S; Nagarajan M; Ramakrishnan C; Fine J Drug Saf; 2018 Jun; 41(6):579-590. PubMed ID: 29446035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]